These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 30648505)

  • 21. Dysregulated FGF signalling in neoplastic disorders.
    Tanner Y; Grose RP
    Semin Cell Dev Biol; 2016 May; 53():126-35. PubMed ID: 26463732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of fibroblast growth factors in tumor growth.
    Korc M; Friesel RE
    Curr Cancer Drug Targets; 2009 Aug; 9(5):639-51. PubMed ID: 19508171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblast growth factor family aberrations in cancers: clinical and molecular characteristics.
    Parish A; Schwaederle M; Daniels G; Piccioni D; Fanta P; Schwab R; Shimabukuro K; Parker BA; Helsten T; Kurzrock R
    Cell Cycle; 2015; 14(13):2121-8. PubMed ID: 25950492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast Growth Factor (FGF) Receptor/FGF Inhibitors: Novel Targets and Strategies for Optimization of Response of Solid Tumors.
    Hierro C; Rodon J; Tabernero J
    Semin Oncol; 2015 Dec; 42(6):801-19. PubMed ID: 26615127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroblast growth factor (FGF), FGF receptor (FGFR), and cyclin D1 (CCND1) DNA methylation in head and neck squamous cell carcinomas is associated with transcriptional activity, gene amplification, human papillomavirus (HPV) status, and sensitivity to tyrosine kinase inhibitors.
    Bao Y; Gabrielpillai J; Dietrich J; Zarbl R; Strieth S; Schröck F; Dietrich D
    Clin Epigenetics; 2021 Dec; 13(1):228. PubMed ID: 34933671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutics Targeting FGF Signaling Network in Human Diseases.
    Katoh M
    Trends Pharmacol Sci; 2016 Dec; 37(12):1081-1096. PubMed ID: 27992319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring the FGF/FGFR System in Ocular Tumors: New Insights and Perspectives.
    Loda A; Turati M; Semeraro F; Rezzola S; Ronca R
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer.
    Brooks AN; Kilgour E; Smith PD
    Clin Cancer Res; 2012 Apr; 18(7):1855-62. PubMed ID: 22388515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FGFR signalling in women's cancers.
    Fearon AE; Gould CR; Grose RP
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2832-42. PubMed ID: 24148254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-canonical fibroblast growth factor signalling in angiogenesis.
    Murakami M; Elfenbein A; Simons M
    Cardiovasc Res; 2008 May; 78(2):223-31. PubMed ID: 18056763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FGF receptors: cancer biology and therapeutics.
    Katoh M; Nakagama H
    Med Res Rev; 2014 Mar; 34(2):280-300. PubMed ID: 23696246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma.
    Tamburello M; Altieri B; Sbiera I; Sigala S; Berruti A; Fassnacht M; Sbiera S
    Endocrine; 2022 Sep; 77(3):411-418. PubMed ID: 35583844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FGFR Fusions in Cancer: From Diagnostic Approaches to Therapeutic Intervention.
    De Luca A; Esposito Abate R; Rachiglio AM; Maiello MR; Esposito C; Schettino C; Izzo F; Nasti G; Normanno N
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Approaches targeting the FGF-FGFR system: a review of the recent patent literature and associated advanced therapeutic agents.
    Herbert C; Lassalle G; Alcouffe C; Bono F
    Pharm Pat Anal; 2014; 3(6):585-612. PubMed ID: 25489913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [FGF/FGFR signalling: Implication in oncogenesis and perspectives].
    Flippot R; Kone M; Magné N; Vignot S
    Bull Cancer; 2015 Jun; 102(6):516-26. PubMed ID: 25986739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isoforms of receptors of fibroblast growth factors.
    Gong SG
    J Cell Physiol; 2014 Dec; 229(12):1887-95. PubMed ID: 24733629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells.
    Marek L; Ware KE; Fritzsche A; Hercule P; Helton WR; Smith JE; McDermott LA; Coldren CD; Nemenoff RA; Merrick DT; Helfrich BA; Bunn PA; Heasley LE
    Mol Pharmacol; 2009 Jan; 75(1):196-207. PubMed ID: 18849352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycosylation of FGF/FGFR: An underrated sweet code regulating cellular signaling programs.
    Gędaj A; Gregorczyk P; Żukowska D; Chorążewska A; Ciura K; Kalka M; Porębska N; Opaliński Ł
    Cytokine Growth Factor Rev; 2024 Jun; 77():39-55. PubMed ID: 38719671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FGF-FGFR signaling in vertebrate organogenesis.
    Kato S; Sekine K
    Cell Mol Biol (Noisy-le-grand); 1999 Jul; 45(5):631-8. PubMed ID: 10512194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex.
    Venkataraman G; Raman R; Sasisekharan V; Sasisekharan R
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3658-63. PubMed ID: 10097093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.